Yates to head EMD Millipore

EMD Millipore, a unit of Merck KGaA, has tapped Robert Yates as its president, effective Sept. 1. He previously was a member of the Roche diagnostics division, where he led the life science business in Penzberg, Germany. EMD Millipore release

Suggested Articles

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.

Illumina will drop $8 billion to reacquire its former spinout, which after nearly five years is nearing completion of its cancer-seeking blood test.

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.